-
CRISPR Therapeutics' (CRSP) "Buy" Rating Reiterated at Needham & Company LLC
来源: Buzz FX / 14 1月 2025 08:36:16 America/New_York
CRISPR Therapeutics' (CRSP) "Buy" Rating Reiterated at Needham & Company LLC Written by MarketBeat January 14, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "buy" rating reaffirm
Read more...